Search for: "Roche v. Roche"
Results 461 - 480
of 925
Sorted by Relevance
|
Sort by Date
2 Nov 2010, 6:58 am
SpeechNow v. [read post]
17 Jan 2008, 10:00 pm
: (Against Monopoly),Structuring a decentralized world - Institute for Ethics and Emerging Technologies: The necessity of open biotechnology: (Patent Lens),A skeptical look at the Automated Content Access Protocol: (Ars Technica),5 practical things to incorporate in a corporate IP strategy: (IP ThinkTank), Legal models for online content enforcement: (OpenContentLawyer),Germany, Chinese copies and misdirected ‘strategy': (IP… [read post]
3 Nov 2010, 11:24 am
”); Roche Prods., Inc. v. [read post]
25 Jan 2016, 3:32 pm
Roche Partner O’Rielly & Roche LLPdena@oriellyroche.com [read post]
14 Aug 2008, 7:22 pm
Hoffman-La Roche Ltd. v. [read post]
2 Mar 2016, 12:10 pm
Roche Partner O’Rielly & Roche LLPdena@oriellyroche.com [read post]
11 Nov 2009, 4:02 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: EU: Generics producers: Criminal sanctions can stop counterfeit drugs (IP Watch) Prandin (Repaglinide) - US: Federal Circuit grants stay of preliminary relief pending full appellate review: Novo Nordisk v Caraco (Patently-O) General Eduardo Pisani of Bristol-Myers Squibb is the new IFPMA Director General (IP Watch) Is the practice of medicine… [read post]
25 Jan 2016, 3:32 pm
Roche Partner O’Rielly & Roche LLPdena@oriellyroche.com [read post]
2 Mar 2016, 12:10 pm
Roche Partner O’Rielly & Roche LLPdena@oriellyroche.com [read post]
11 Nov 2009, 4:02 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: EU: Generics producers: Criminal sanctions can stop counterfeit drugs (IP Watch) Prandin (Repaglinide) - US: Federal Circuit grants stay of preliminary relief pending full appellate review: Novo Nordisk v Caraco (Patently-O) General Eduardo Pisani of Bristol-Myers Squibb is the new IFPMA Director General (IP Watch) Is the practice of medicine… [read post]
20 Jul 2023, 3:44 am
Rodriguez (Finnegan), in an afternoon panel discussion on plausibility in all its guises, chaired by Greg Corcoran (ASML).Further readingUK courtsNo pain, no gain: Plausibility in Warner-Lambert v Actavis (2018)Takeda v Roche: "Is it plausible? [read post]
17 Apr 2017, 9:59 pm
Roche Palo Alto LLC v. [read post]
25 Oct 2018, 10:16 am
(citing Jewel v. [read post]
31 Oct 2008, 11:53 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Oxytrol (Oxybutynin) - US: Watson files patent infringement lawsuit against Barr over application to market generic Oxytrol; Barr challenges Oxytrol patent… [read post]
25 Oct 2018, 10:16 am
(citing Jewel v. [read post]
15 Dec 2010, 2:17 am
General Coming soon: International Classification of traditional medicine by WHO (Spicy IP) Teva Pharma uses online game to promote generic substitution (Patent Baristas) Australia: APO: Success of phase 3 trials ‘obvious’ in view of phase 1 and 2: Genentec, Inc (Patentology) Brazil: Government support to impel Brazil generic market (GenericsWeb) EU: EPO Enlarged Board of Appeal decides Broccoli (G2/07) and Tomatoes (G1/08) – essentially biological breeding processes not patentable… [read post]
19 Aug 2007, 7:46 am
State v. [read post]
3 Nov 2020, 10:28 pm
Guenther v. [read post]
25 Feb 2014, 1:04 pm
Rogers, Bernard Jolin, Nicolas Roche. [read post]
20 Feb 2007, 2:51 am
Content in this issue includes* co-editor Véronique Musson's cover story on the controversial issue of the registration of Lego bricks as trade marks and the consequent patchiness of legal protection;* Vladimir Biriulin writing on the efforts made by Russia to update its trade mark registration and enforcement infrastructure in the light of modern commercial and industrial needs;* Matthias Koch and Kathrin Samwer (Freshfields Bruckhaus Deringer's Cologne office)… [read post]
